Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model
This study broadens the evidence from previous studies that Upreti is more favorable than Salem, but further work is needed especially in the neonatal and early infant age range.PMID:38696325 | DOI:10.1002/jcph.2452
Source: The Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Marc Codaccioni Rosalind L Southall Jean Dinh Trevor N Johnson Source Type: research
More News: Drugs & Pharmacology | Fentanyl | Pediatrics | Perinatology & Neonatology | Study | Viagra